13 followers
@BrielmaierL Didn't the trial involving igf-1 fail? https://t.co/JHeAPR5rtu
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Overview of attention for article published in Neurology, November 2008
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 144 Mendeley